GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (STU:1FX) » Definitions » Debt-to-EBITDA

Ananda Developments (STU:1FX) Debt-to-EBITDA : 0.00 (As of Jul. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Developments Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ananda Developments's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was €0.00 Mil. Ananda Developments's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2023 was €0.00 Mil. Ananda Developments's annualized EBITDA for the quarter that ended in Jul. 2023 was €-1.97 Mil. Ananda Developments's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ananda Developments's Debt-to-EBITDA or its related term are showing as below:

STU:1FX's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.67
* Ranked among companies with meaningful Debt-to-EBITDA only.

Ananda Developments Debt-to-EBITDA Historical Data

The historical data trend for Ananda Developments's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Debt-to-EBITDA Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Debt-to-EBITDA
- -0.23 -0.54 -1.63 -4.18

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -2.81 -0.89 -2.55 -

Competitive Comparison of Ananda Developments's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ananda Developments's Debt-to-EBITDA falls into.



Ananda Developments Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ananda Developments's Debt-to-EBITDA for the fiscal year that ended in Jan. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.183 + 0) / -1.001
=-4.18

Ananda Developments's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -1.966
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jul. 2023) EBITDA data.


Ananda Developments  (STU:1FX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ananda Developments Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments Headlines

No Headlines